Inactive Instrument
Cotinga Pharmaceuticals Inc. Stock Toronto S.E.
Stocks
COT.H
CA22164W1059
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -41.67% |
| Manager | Title | Age | Since |
|---|---|---|---|
Alison Silva
CEO | Chief Executive Officer | 48 | 2016-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
John Drake
CHM | Chairman | - | 2007-02-19 |
David Sanderson
BRD | Director/Board Member | - | 2013-12-04 |
| Director/Board Member | 65 | 2018-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -41.67% | -22.22% | - | - | 2.2K | |
| +2.07% | +13.76% | +65.44% | +106.53% | 70.1B | |
| -0.87% | +0.08% | +36.96% | +65.91% | 54.93B | |
| -4.50% | -4.69% | +2.82% | +463.22% | 28.89B | |
| -0.66% | -0.74% | +47.70% | +6.98% | 23.9B | |
| -0.67% | +1.02% | -18.32% | -13.84% | 23.3B | |
| +0.35% | +12.02% | +257.19% | +466.50% | 18.41B | |
| -0.59% | +7.88% | +40.87% | -20.56% | 18.77B | |
| -0.38% | -3.43% | +20.16% | +613.70% | 16.1B | |
| +0.46% | -3.05% | +31.49% | +135.18% | 12.48B | |
| Average | -4.67% | +4.71% | +53.81% | +202.62% | 29.65B | |
| Weighted average by Cap. | -0.27% | +3.98% | +51.08% | +165.18% |
Employees
6
